iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

NCT03192501 · clinicaltrials.gov ↗

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Gene Abnormality
Gene Product Sequence Variation
Cancer

Interventions

DRUG: inhibitors, ADC drugs such as tarceva, capmatinib, padcev et al for A/C group.

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Collaborators

[object Object]
[object Object]